MCID: HYD006
MIFTS: 67

Hydrocephalus malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Blood diseases, Bone diseases, Fetal diseases, Gastrointestinal diseases

Aliases & Classifications for Hydrocephalus

About this section

Aliases & Descriptions for Hydrocephalus:

Name: Hydrocephalus 34 11 47 48 26 49 37 38 13 67
Hydrocephalus, Nonsyndromic, Autosomal Recessive 1 67
Hydrocephalus, Nonsyndromic, Autosomal Recessive 11
Hydrocephalus Adverse Event 67
 
Hydrocephalus, X-Linked 11
Ventriculomegaly 47
Hydrocephaly 47

Classifications:



External Ids:

Disease Ontology11 DOID:10908
ICD1029 G91, G91.9
MeSH38 D006849
NCIt44 C3111

Summaries for Hydrocephalus

About this section
MedlinePlus:37 Hydrocephalus is the buildup of too much cerebrospinal fluid in the brain. normally, this fluid cushions your brain. when you have too much, though, it puts harmful pressure on your brain. hydrocephalus can be congenital, or present at birth. causes include genetic problems and problems with how the fetus develops. an unusually large head is the main sign of congenital hydrocephalus. hydrocephalus can also happen after birth. this is called acquired hydrocephalus. it can occur at any age. causes can include head injuries, strokes, infections, tumors, and bleeding in the brain. symptoms include headache vomiting and nausea blurry vision balance problems bladder control problems thinking and memory problems hydrocephalus can permanently damage the brain, causing problems with physical and mental development. if untreated, it is usually fatal. with treatment, many people lead normal lives with few limitations. treatment usually involves surgery to insert a shunt. a shunt is a flexible but sturdy plastic tube. the shunt moves the cerebrospinal fluid to another area of the body where it can be absorbed. medicine and rehabilitation therapy can also help. nih: national institute of neurological disorders and stroke

MalaCards based summary: Hydrocephalus, also known as hydrocephalus, nonsyndromic, autosomal recessive 1, is related to mucopolysaccharidoses and empty sella syndrome, and has symptoms including back pain, back pain and headache. An important gene associated with Hydrocephalus is L1CAM (L1 Cell Adhesion Molecule), and among its related pathways are Central carbon metabolism in cancer and CTLA4 Signaling. Affiliated tissues include brain, testes and spinal cord, and related mouse phenotypes are respiratory system and digestive/alimentary.

Disease Ontology:11 A cerebral degeneration characterized by an abnormal accumulation of cerebrospinal fluid in the ventricles of the brain, leading to progressive enlargement of the head.

NINDS:48 Hydrocephalus is a condition in which the primary characteristic is excessive accumulation of cerebrospinal fluid (CSF) -- the clear fluid that surrounds the brain and spinal cord. This excessive accumulation results in an abnormal dilation of the spaces in the brain called ventricles. This dilation causes potentially harmful pressure on the tissues of the brain. Hydrocephalus may be congenital or acquired. Congenital hydrocephalus is present at birth and may be caused by genetic abnormalities or

Wikipedia:70 Hydrocephalus is a condition in which there is an abnormal accumulation of cerebrospinal fluid (CSF)... more...

Related Diseases for Hydrocephalus

About this section

Diseases in the Hydrocephalus family:

Hydrocephalus, Autosomal Dominant Hydrocephalus, Nonsyndromic, Autosomal Recessive 2
Hydrocephalus, Nonsyndromic, Autosomal Recessive Hydrocephalus Due to Aqueductal Stenosis
Hydrocephalus Due to Congenital Stenosis of Aqueduct of Sylvius Hydrocephalus Autosomal Recessive
Nonsyndromic Hydrocephalus, Ccdc88c-Related Nonsyndromic Hydrocephalus, Mpdz-Related
Congenital Hydrocephalus

Diseases related to Hydrocephalus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 521)
idRelated DiseaseScoreTop Affiliating Genes
1mucopolysaccharidoses29.8AKT3, CCND2, PIK3R2
2empty sella syndrome29.5GFAP, NES
3anaplastic oligodendroglioma29.5GFAP, NES
4medulloblastoma28.7CCND2, GFAP, NES, SYP
5normal pressure hydrocephalus12.3
6hydrocephalus due to aqueductal stenosis12.3
7ventriculomegaly with cystic kidney disease12.2
8chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia12.2
9proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome12.2
10communicating hydrocephalus12.0
11megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 112.0
12hydrocephalus, endocardial fibroelastosis, and cataracts12.0
13obstructive hydrocephalus12.0
14hydrocephalus, nonsyndromic, autosomal recessive12.0
15megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 212.0
16megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 312.0
17hydrocephalus, nonsyndromic, autosomal recessive 212.0
18congenital hydrocephalus11.9
19congenital communicating hydrocephalus11.9
20congenital non-communicating hydrocephalus11.8
21masa syndrome11.8
22isolated dandy-walker malformation without hydrocephalus11.7
23isolated dandy-walker malformation with hydrocephalus11.7
24bor-duane hydrocephalus contiguous gene syndrome11.7
25vacterl with hydrocephalus11.7
26dandy-walker syndrome11.7
27hydrocephalus due to congenital stenosis of aqueduct of sylvius11.7
28thoracic dysplasia-hydrocephalus syndrome11.7
29hydrocephalus, sprengel anomaly, and costovertebral dysplasia11.7
30hydrocephalus, autosomal dominant11.7
31hydrocephalus obesity hypogonadism11.7
32nonsyndromic hydrocephalus, mpdz-related11.7
33dandy-walker malformation with sagittal craniosynostosis and hydrocephalus11.6
34megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic11.6
35nonsyndromic hydrocephalus, ccdc88c-related11.6
36hydrocephalus with cerebellar agenesis11.6
37hydrocephalus, tall stature, joint laxity, and kyphoscoliosis11.6
38hydrocephalus with associated malformations11.6
39amelia cleft lip palate hydrocephalus iris coloboma11.6
40hydrocephalus autosomal recessive11.6
41hydrocephalus craniosynostosis bifid nose11.6
42hydrocephalus growth retardation skeletal anomalies11.6
43hydrocephalus skeletal anomalies11.6
44hydrocephalus-cleft palate-joint contractures syndrome11.6
45tibial aplasia ectrodactyly hydrocephalus11.6
46vacterl with hydrocephalus, fancb-related11.6
47x-linked hydrocephalus with stenosis of the aqueduct of sylvius11.6
48craniosynostosis-hydrocephalus-arnold-chiari malformation type i-radioulnar synostosis syndrome11.6
49chudley-mccullough syndrome11.5
50vacterl association, x-linked11.5

Graphical network of the top 20 diseases related to Hydrocephalus:



Diseases related to hydrocephalus

Symptoms for Hydrocephalus

About this section

UMLS symptoms related to Hydrocephalus:


back pain, headache, pain, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, sleeplessness, pain, not elsewhere classified

Drugs & Therapeutics for Hydrocephalus

About this section

Drugs for Hydrocephalus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 94)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CitalopramapprovedPhase 450359729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
2Serotonin AgentsPhase 43102
3Serotonin Uptake InhibitorsPhase 41570
4Neurotransmitter Uptake InhibitorsPhase 43464
5Cholinergic AgentsPhase 43846
6
SerotoninPhase 4356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
7Muscarinic AntagonistsPhase 41134
8Cholinergic AntagonistsPhase 41658
9Neurotransmitter AgentsPhase 4, Phase 317734
10
Midazolamapproved, illicitPhase 368459467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
11
Clindamycinapproved, vet_approvedPhase 316818323-44-929029
Synonyms:
13441-63-9
16669-21-9
18323-44-9
21462-39-5 (mono-hydrochloride)
24620-78-8
24696-19-3
58207-19-5
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
7-Chlorolincomycin
7-Deoxy-7(S)-chlorolincomycin
AC1L1EGQ
AC1L1GLA
AC1L9JV8
AC1MHD7N
AC1MHE1M
AC1MHUOE
AC1MHX4G
AC1NWAKO
AC1O7ENS
AC1O7GED
AC1OFCIP
AC1OFCIV
AC1OFCJ1
AC1OFCJ7
AC1OIBYJ
AC1OIBYL
AC1OIBYN
AC1Q2V4O
Antirobe
BIDD:GT0418
BPBio1_000236
BRD-A23034328-003-03-4
BSPBio_000214
BSPBio_002049
C06914
C18H33ClN2O5S
CAS-21462-39-5
CHEBI:3745
CHEMBL187
CID2786
CID29029
CID3000512
CID3001928
CID3032758
CID3034218
CID446598
CID5702026
CID6602476
CID6604361
CID7048642
CID7048644
CID7048646
CID7048648
CID7276014
CID7276016
CID7276018
CID9812677
CLDM
CLINDA & IL-12
CLY
Chlolincocin
Chlorlincocin
Chlorodeoxylincomycin
Chlorolincomycin
Cleocin
Cleocin (TN)
Cleocin (tn)
Cleocin HCl
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
Cleocin T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
 
Clinda-Derm
ClindaDerm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
Clindamycin
Clindamycin & Interleukin 12
Clindamycin & VRC3375
Clindamycin (USAN/INN)
Clindamycin Hcl
Clindamycin Hydrochloride
Clindamycin Phosphate
Clindamycin [USAN:BAN:INN]
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
D00277
DB01190
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Dalacine
DivK1c_000464
EINECS 242-209-1
Evoclin
HMS2089A05
HMS2089N16
HSDB 3037
I06-0826
IDI1_000464
KBio1_000464
KBio2_000638
KBio2_003206
KBio2_005774
KBio3_001269
KBioGR_000844
KBioSS_000638
Klimicin
Klindan 300
LS-187128
LS-98131
MLS001183714
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
MolPort-002-323-206
MolPort-002-964-479
NCGC00016752-01
NCGC00178843-01
NCGC00179636-01
NINDS_000464
Prestwick0_000137
Prestwick1_000137
Prestwick2_000137
Prestwick3_000137
ResiDerm A
SMP2_000295
SMR000677917
SPBio_000670
SPBio_002153
STK177246
STOCK1N-31150
Sobelin
Spectrum2_000885
Spectrum3_000355
Spectrum4_000292
Spectrum5_001525
Spectrum_000158
U 21251
U-21,251
U-21251
UNII-3U02EL437C
Zindaclin
clindamycin
12
RifampinapprovedPhase 333713292-46-15458213, 5381226
Synonyms:
1-b]furan-21-yl acetate
13292-46-1
3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin
3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
3-(4-Methylpiperazinyliminomethyl)-rifamycin SV
3-(4-Methylpiperazinyliminomethyl)rifamycin SV
3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV
3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV
3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin
46713_FLUKA
46713_RIEDEL
62534-43-4
8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV
8-(4-Methylpiperazinyliminomethyl) rifamycin SV
8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin
8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv
8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv
83907_FLUKA
83907_SIGMA
8CI)
AZT + Rifampin
Abrifam
Archidyn
Arficin
Arzide
BA-41166E
BIDD:PXR0014
BPBio1_000561
BSPBio_000509
Ba 41166
Ba 41166/E
Benemicin
Benemycin
Bio-0621
C06688
C43H58N4O12
CAS-13292-46-1
CCRIS 551
CHEBI:28077
CHEBI:455936
CHEMBL180
CID5381226
CID5388984
CID5458213
CID5702112
CID6604339
CID6708473
CID6842115
CID6912767
CID6913622
CPD001906767
D00211
DB01045
DRG-0109
Dione 21-acetate
Dipicin
DivK1c_000550
Doloresum
EINECS 236-312-0
Eremfat
Famcin
Fenampicin
HMS1569J11
HMS1920P08
HMS2089F12
HMS2092G09
HMS501L12
HSDB 3181
KBio1_000550
KBio2_000919
KBio2_003487
KBio2_006055
KBio3_003018
KBioGR_001780
KBioSS_000919
L-5103
L-5103 Lepetit
LS-7689
MLS000028552
MLS001148237
MLS001333745
MolPort-000-767-051
MolPort-002-513-586
MolPort-003-666-281
MolPort-006-395-891
NCGC00016699-01
NCGC00017365-01
NCGC00018178-01
NCGC00022678-03
NCGC00022678-04
NCGC00022678-05
NCGC00160500-01
 
NCI60_000309
NINDS_000550
NSC 113926
NSC-113926
NSC113926
Piperine & Rifampicin
Prestwick0_000525
Prestwick1_000525
Prestwick2_000525
Prestwick3_000525
Prestwick_833
R-Cin
R/AMP
R0079
R3501_SIAL
R3501_SIGMA
R5777_SIGMA
R7382_SIGMA
RAMP
RFP
RMP
Ramp
Reserpine & Rifampicin
Rf
Rfamipicin
Rifa
Rifadin
Rifadin (TN)
Rifadin I.V
Rifadin I.V.
Rifadin IV
Rifadin Iv
Rifadin, Rimactane, Rifampicin, Rifampin
Rifadine
Rifagen
Rifaldazin
Rifaldazine
Rifaldin
Rifam
Rifamicin AMP
Rifamor
Rifampicin
Rifampicin & EEP
Rifampicin & Propolis
Rifampicin (JP15/INN)
Rifampicin SV
Rifampicin [INN:BAN:JAN]
Rifampicina
Rifampicina [INN-Spanish]
Rifampicine
Rifampicine [French]
Rifampicinum
Rifampicinum [INN-Latin]
Rifampin
Rifampin (USP)
Rifampin [USAN]
Rifamsolin
Rifamycin
Rifamycin AMP
Rifamycin Amp
Rifaprodin
Rifcin
Rifinah
Rifobac
Rifoldin
Rifoldine
Riforal
Rimactan
Rimactane
Rimactane (TN)
Rimactazid
Rimactin
Rimactizid
Rimazid
Rimycin
Rofact
S1764_Selleck
SAM002264646
SMR000058322
SMR000653525
SPBio_002430
SPECTRUM1500529
STK080143
Sinerdol
Spectrum3_001837
Spectrum4_001250
Spectrum5_002018
Spectrum_000439
TNP00313
Tubocin
UNII-VJT6J7R4TR
WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1
nchembio884-comp4
rifampin
13
Acetazolamideapproved, vet_approvedPhase 37559-66-51986
Synonyms:
1424-27-7 (mono-hydrochloride salt)
1yda
1ydb
1ydd
1zsb
2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
2h4n
3czv
4-Diamox
5-ACETAMIDO-1,3,4-thiadiazole-2-sulfonamide
5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
5661-25-6
59-66-5
8017-69-4
A 6011
A6011_SIAL
A6011_SIGMA
AB00051906
AC-12779
AC1L1CO5
AI3-52458
AKOS000715163
Acetadiazol
Acetamidothiadiazolesulfonamide
Acetamox
Acetazolam
Acetazolamid
Acetazolamida
Acetazolamida [INN-Spanish]
Acetazolamide (AAZ)
Acetazolamide (JP15/USP/INN)
Acetazolamide Apotex Brand
Acetazolamide Chiesi Brand
Acetazolamide Dioptic Brand
Acetazolamide Grin Brand
Acetazolamide ICN Brand
Acetazolamide Jumer Brand
Acetazolamide Llorens Brand
Acetazolamide Medphano Brand
Acetazolamide Novopharm Brand
Acetazolamide Orion Brand
Acetazolamide Sodium
Acetazolamide Sodium, (Sterile)
Acetazolamide Wassermann Brand
Acetazolamide [INN:BAN:JAN]
Acetazolamide, Monosodium Salt
Acetazolamidum
Acetazolamidum [INN-Latin]
Acetazolamine
Acetazoleamide
Acetozalamide
Acétazolamide
Ak Zol
Ak-Zol
AkZol
Apo Acetazolamide
Apo-Acetazolamide
ApoAcetazolamide
Apotex Brand of Acetazolamide
Atenezol
BAS 01585728
BIDD:GT0643
BPBio1_000007
BSPBio_000005
BSPBio_001788
C06805
C4H6N4O3S2
CAS-59-66-5
CCRIS 5811
CHEBI:27690
CHEMBL20
CID1986
CPD0-1626
CPD000058394
Carbonic Anhydrase Inhibitor 6063
Carbonic Anhydrase Inhibitor No. 6063
Carbonic anhydrase inhibitor 6063
Chiesi Brand of Acetazolamide
Ciba Vision Brand of Acetazolamide
Cidamex
D000086
D00218
DB00819
Dazamide
Defiltran
Dehydratin
Diacarb
Diakarb
Diamox
Diamox (TN)
Diamox Sequels
Didoc
Diluran
 
Dioptic Brand of Acetazolamide
Diuramid
Diuramide
Diureticum-Holzinger
Diureticum-holzinger
Diuriwas
Diutazol
DivK1c_000017
Donmox
Duiramid
EINECS 200-440-5
EU-0100039
Edemox
Eumicton
Fonurit
Glauconox
Glaumox
Glaupax
Glupax
Grin Brand of Acetazolamide
HMS1568A07
HMS1920A05
HMS2091G05
HMS500A19
HSDB 3002
Huma Zolamide
Huma-Zolamide
HumaZolamide
I09-0425
ICN Brand of Acetazolamide
IDI1_000017
Jumer Brand of Acetazolamide
KBio1_000017
KBio2_000358
KBio2_002926
KBio2_005494
KBio3_001288
KBioGR_000558
KBioSS_000358
LS-10227
Llorens Brand of Acetazolamide
Lopac-A-6011
Lopac0_000039
MLS000028435
MLS001148438
Medphano Brand of Acetazolamide
MolPort-001-783-578
Monosodium Salt Acetazolamide
N-[5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide
N-[5-(Aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide
NCGC00015074-01
NCGC00015074-02
NCGC00015074-03
NCGC00015074-06
NCGC00015074-11
NCGC00023455-03
NCGC00023455-04
NCGC00023455-05
NCGC00023455-06
NCGC00023455-07
NINDS_000017
NSC 145177
NSC145177
Natrionex
Nephramid
Nephramide
Novopharm Brand of Acetazolamide
Orion Brand of Acetazolamide
Phonurit
Prestwick0_000003
Prestwick1_000003
Prestwick2_000003
Prestwick3_000003
Prestwick_4
SAM002554883
SBB056640
SK-acetazolamide
SMR000058394
SPBio_000004
SPBio_001926
SPECTRUM1500102
Sk-Acetazolamide
Spectrum2_000082
Spectrum3_000284
Spectrum4_000139
Spectrum5_000738
Spectrum_000018
Storz Brand of Acetazolamide Preparation
Storzolamide
UNII-O3FX965V0I
Vetamox
WLN: T5NN DSJ CSZW EMV1
Wassermann Brand of Acetazolamide
Wyeth Brand of Acetazolamide Preparation
acetazolamide
14
Tranexamic AcidapprovedPhase 2, Phase 32571197-18-85526
Synonyms:
08455_FLUKA
1197-17-7
1197-18-8
1ceb
3-14-00-00868 (Beilstein Handbook Reference)
4-(Aminomethyl)-Cyclohexanecarboxylic Acid
4-(Aminomethyl)cyclohexanecarboxylic acid
4-(aminomethyl)cyclohexane-1-carboxylic acid
857653_ALDRICH
A0236
AB00052260
AB1003647
AC-4687
AC1L1KJH
AC1Q50F3
AC1Q546D
AC1Q5U04
ALBB-006013
AMCA
AMCHA
AMH
AR-1F6595
Acide tranexamique
Acide tranexamique [INN-French]
Acido tranexamico
Acido tranexamico [INN-Spanish]
Acidum tranexamicum
Acidum tranexamicum [INN-Latin]
Amikapron
Amstat
Anvitoff
BAY 3517
BPBio1_000069
BRN 2207452
BSPBio_000061
BSPBio_002837
CAS-1197-18-8
CHEBI:48669
CHEMBL292500
CHEMBL877
CID5526
CL 65336
CL-65336
Carxamin
Cyclocapron
Cyklokapron
Cyklokapron (TN)
D01136
DB00302
DV 79
DV-79
DV79
DivK1c_000655
EINECS 214-818-2
Emorhalt
Exacyl
Frenolyse
HMS1568D03
HMS1921F08
HMS2092P03
HMS502A17
Hexapromin
Hexatron
I04-0993
IDI1_000655
KABI 2161
KBio1_000655
KBio2_001871
KBio2_004439
KBio2_007007
KBio3_002337
KBioGR_000511
 
KBioSS_001871
LS-56611
LS-56612
LT00159441
Mastop
MolPort-001-792-390
MolPort-002-512-008
NCGC00016569-01
NCGC00016569-02
NCGC00016569-03
NCGC00094944-01
NCGC00094944-02
NINDS_000655
NSC 291305
NSC291305
Oprea1_786414
Prestwick0_000171
Prestwick1_000171
Prestwick2_000171
Prestwick3_000171
Prestwick_476
RP 18,429
Rikavarin
Rikavarin (TN)
Rikavarin-S
SPBio_000689
SPBio_001982
SPECTRUM1502026
STK503668
STOCK1N-16183
Spectrum2_000655
Spectrum3_001189
Spectrum4_000046
Spectrum5_001258
Spectrum_001391
Spiramin
Tamcha
Tranex
Tranexamate
Tranexamic acid (JP15/USAN/INN)
Tranexamic acid [USAN:INN:BAN:JAN]
Tranexamic acid cis-form
Tranexamsaeure
Tranexan
Tranexmic acid
Tranhexamic acid
Trans AMCHA
Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid
Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid
Trans-p-(Aminomethyl)cyclohexanecarboxylic
Transamin
Transamin (TN)
Transamlon
Trasamlon
UNII-6T84R30KC1
Ugurol
WLN: L6TJ AVQ D1Z -T
cis-4-(Aminomethyl)cyclohexanecarboxylic acid
cis-4-Aminomethylcyclohexane-1-carboxylic acid
cis-AMCHA
t-AMCHA
tranexamic acid
tranexmic acid
trans-1-Aminomethylcyclohexane-4-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-carboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester
trans-4-Aminomethylcyclohexane-1-carboxylic acid
trans-4-aminomethylcyclohexane-1-carboxylic acid
trans-Amcha
trans-Tranexamic acid
trans-p-(Aminomethyl)cyclohexanecarboxylic acid
15
Dexmedetomidineapproved, vet_approvedPhase 354076631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
16
Isofluraneapproved, vet_approvedPhase 316526675-46-73763
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether
2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane
26675-46-7
AC-154802
AC1L1GNN
AErrane (Veterinary)
Aerrane
BRN 1852087
C07518
CCRIS 3043
CHEBI:6015
CHEMBL1256
CID3763
Compound 469
D00545
D007530
DB00753
EINECS 247-897-7
Ethane
Ether, 1-chloro-2,2,2-trifluoroethyl difluoromethyl
 
Forane
Forane (TN)
Forene
I14-1303
IsoFlo
Isoflurane
Isoflurane (JP15/USP/INN)
Isoflurane [Anaesthetics, volatile]
Isoflurane [USAN:BAN:INN:JAN]
Isoflurane [USAN:INN:BAN:JAN]
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isoflurano [INN-Spanish]
Isofluranum
Isofluranum [INN-Latin]
Jsp005223
LS-7462
MolPort-000-153-606
NCGC00181037-01
R-E 235dal
ST51041445
UNII-CYS9AKD70P
isoflurane
17
RemifentanilapprovedPhase 3446132875-61-760815
Synonyms:
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
132539-07-2 (mono-hydrochloride)
132875-61-7
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
 
DEA No. 9739
GI 87084B
GI 87084X
GI87084B
L001266
LS-115982
MolPort-004-286-006
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanyl
UNII-P10582JYYK
Ultiva
Ultiva (TN)
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
18
Caffeineapproved, NutraceuticalPhase 338058-08-22519
Synonyms:
07E4FB58-FD79-4175-8E3D-05BF96954522
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-Trimethylxanthine
1,3,7-trimethyl-2,6-dioxopurine
1,3,7-trimethylpurine-2,6-dione
1,3,7-trimethylxanthine
1-3-7-TRIMETHYLXANTHINE
1-Methyl-Theobromine
1-methyltheobromine
137X
1gfz
1l5q
1l7x
27602_FLUKA
2a3b
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
3,7-dihydro-1,3,7-trimethyl-1H-purine
5-26-13-00558 (Beilstein)
58-08-2
7-Methyl Theophylline
7-Methyltheophylline
7-methyltheophylline
71701-02-5
75035_FLUKA
95789-13-2
A.S.A. and Codeine Compound
AC-12774
AC1L1DV2
AC1Q3Z23
ACon1_000085
AI3-20154
AKOS000121334
Alert-Pep
Alert-pep
Anacin Maximum Strength
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anhydrous caffeine (TN)
Anoquan
BIDD:ER0554
BIDD:GT0632
BIDD:PXR0172
BIM-0050216.0001
BRD-K02404261-001-02-7
BRD-K02404261-001-03-5
BRN 0017705
BSPBio_001921
Berlin-Chemie Brand of Caffeine
Bio-0579
Bio1_000473
Bio1_000962
Bio1_001451
Bristol-Myers Squibb Brand of Caffeine
C 0750
C07481
C0750_SIAL
C1778_SIAL
C2042
C6035_FLUKA
C6035_SIGMA
C7731_SIAL
C8960_SIAL
CCRIS 1314
CFF
CHEBI:27732
CHEMBL113
CID2519
CU-01000012617-3
Cafamil
Cafcit
Cafecon
Cafeina
Cafergot
Cafeína
Caffedrine
Caffedrine Caplets
Caffein
Caffeina
Caffeina [Italian]
Caffeine (USP)
Caffeine (natural)
Caffeine Pure
Caffeine [BAN:JAN]
Caffeine solution
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeine, anhydrous
Caffeine, synthetic
Caffeinum
Caffine
Cafipel
Caféine
Coffein
Coffein [German]
Coffeine
Coffeinum
Coffeinum N
Coffeinum Purrum
Compound 65
D002110
D00528
DB00201
DHC Plus
DHCplus
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
DivK1c_000730
Durvitan
EINECS 200-362-1
EU-0100228
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA No. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline Brand of Caffeine
Guaranine
HMS1920I09
HMS2091O11
HMS502E12
HSDB 36
Hycomine
Hycomine Compound
I14-4386
 
IDI1_000730
Invagesic
Invagesic Forte
KBio1_000730
KBio2_001781
KBio2_004349
KBio2_006917
KBio3_001141
KBioGR_002325
KBioSS_001781
Keep Alert
Kofein
Kofein [Czech]
Koffein
Koffein [German]
L000155
LS-237
Lanorinal
Lopac-C-0750
Lopac0_000228
MEGxp0_001350
MLS001055341
MLS001056714
MLS001066409
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura Brand of Caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Midol Maximum Strength
Migergot
Miudol
MolMap_000054
MolPort-000-730-850
Monohydrate Caffeine
Monomethyl Derivative of Theophylline
Monomethyl derivative of Theophylline
NCGC00015208-01
NCGC00015208-02
NCGC00015208-04
NCGC00015208-14
NCGC00090699-01
NCGC00090699-02
NCGC00090699-03
NCGC00090699-04
NCGC00090699-05
NCGC00090699-06
NCGC00090699-07
NCGC00090699-08
NCGC00090699-09
NCGC00168808-01
NCGC00168808-02
NCI-C02733
NCIOpen2_008255
NINDS_000730
NSC 5036
NSC5036
Natural Caffeinum
Nix Nap
No Doz
No-Doz
Nodaca
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
Organex
Orphengesic
Orphengesic Forte
P-A-C Analgesic Tablets
PDSP1_001016
PDSP1_001235
PDSP2_001000
PDSP2_001219
Passauer Brand of Caffeine
Pep-Back
Percoffedrinol N
Percutafeine
Phensal
Pierre Fabre Brand of Caffeine
Probes1_000150
Probes2_000128
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick Pep
Quick-Pep
Refresh'n
Republic Drug Brand of Caffeine
SDCCGMLS-0064595.P001
SDCCGMLS-0064595.P002
SK 65 Compound
SK-65 Compound
SMR000326667
SPBio_001222
SPECTRUM1500155
STK177283
Seid Brand of Caffeine
Spectrum2_001261
Spectrum3_000321
Spectrum4_001782
Spectrum5_000423
Spectrum_001301
Stim
Synalgos-Dc
TNP00310
Thein
Theine
Theobromine ME
Theobromine Me
Theophylline ME
Theophylline Me
Theophylline, 7-methyl
Thompson Brand 1 of Caffeine
Thompson Brand 2 of Caffeine
Tirend
Tri-Aqua
Triad
UNII-3G6A5W338E
Ultra Pep-Back
Vivarin
W222402_ALDRICH
WLN: T56 BN DN FNVNVJ B1 F1 H1
Wake-Up
Wigraine
Xanthine, 1,3,7-trimethyl
ZINC00001084
bmse000206
cafeine
caffeine
caffenium
component of Cafergot
nchembio.243-comp7
nchembio.63-comp5
nchembio774-comp2
teina
teína
19Pharmaceutical SolutionsPhase 2, Phase 37793
20AnestheticsPhase 2, Phase 39001
21Anti-Infective Agents, LocalPhase 2, Phase 31785
22Caffeine citratePhase 318
23Antibiotics, AntitubercularPhase 36972
24Antitubercular AgentsPhase 31272
25Central Nervous System StimulantsPhase 32132
26Clindamycin palmitatePhase 3168
27Tranquilizing AgentsPhase 34164
28Purinergic P1 Receptor AntagonistsPhase 3348
29Anti-Infective AgentsPhase 321402
30Phosphodiesterase InhibitorsPhase 31254
31Anti-Anxiety AgentsPhase 31816
32Adjuvants, AnesthesiaPhase 31588
33Psychotropic DrugsPhase 36279
34Anesthetics, GeneralPhase 32787
35Central Nervous System DepressantsPhase 312806
36Anesthetics, IntravenousPhase 32406
37GABA ModulatorsPhase 3864
38Anti-Bacterial AgentsPhase 310884
39GABA AgentsPhase 31622
40Clindamycin phosphatePhase 3168
41Hypnotics and SedativesPhase 32485
42gamma-GlobulinsPhase 3317
43Immunoglobulin GPhase 3265
44Immunoglobulins, IntravenousPhase 3324
45AntibodiesPhase 36045
46Rho(D) Immune GlobulinPhase 3317
47ImmunoglobulinsPhase 36045
48Natriuretic AgentsPhase 31645
49AnticonvulsantsPhase 32620
50Peripheral Nervous System AgentsPhase 322776

Interventional clinical trials:

(show top 50)    (show all 137)
idNameStatusNCT IDPhase
1NIMIP: Non Invasive Measurement of the Intracranial PressureUnknown statusNCT01685450Phase 4
2Normal Pressure Hydrocephalus (NPH) RegistryCompletedNCT00233701Phase 4
3A Registry for Comparing Catheter-Related Infection Rates Among Various Shunt Systems in the Treatment of HydrocephalusCompletedNCT00280904Phase 4
4ShuntCheck Versus Radionuclide in Evaluating Shunt Function in Symptomatic NPH PatientsCompletedNCT01323764Phase 4
5NIMI-NICU: Non Invasive Monitoring of the Intracranial Pressure - NeuroIntensive Care UnitCompletedNCT01685476Phase 4
6Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder PatientsCompletedNCT00902421Phase 4
7ShuntCheck-Micro-Pumper Pediatric Clinical Outcomes StudyRecruitingNCT01881711Phase 4
8Effect of Intrathoracic Pressure Regulation on Traumatic Brain InjuryTerminatedNCT01824589Phase 4
9ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) PatientsWithdrawnNCT00793416Phase 4
10Multi-Center Study of ShuntCheckWithdrawnNCT00788385Phase 4
11Neurocognitive Outcomes and Changes in Brain and CSF Volume After Treatment of PIH in Ugandan Infants by Shunting vs ETV/CPCUnknown statusNCT01936272Phase 3
12Clinical Value of Noninvasive Intracranial Pressure MeasurementUnknown statusNCT02130219Phase 2, Phase 3
13A Randomised Controlled Trial of Lumbar Drainage to Treat Communicating Hydrocephalus After Severe Intraventricular HemorrhageCompletedNCT01041950Phase 2, Phase 3
14PET Imaging of Brain Amyloid in Normal Pressure HydrocephalusCompletedNCT01053312Phase 3
15A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System.CompletedNCT00196196Phase 3
16Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular CatheterCompletedNCT00286104Phase 3
17Intraoral 30% Glucose Effect In NewbornsCompletedNCT02325583Phase 3
18Premature Infants in Need of Transfusion (PINT)CompletedNCT00182390Phase 3
19High Versus Low Dose of Caffeine for Apnea of PrematurityCompletedNCT02103777Phase 3
20Caffeine for Apnea of Prematurity (CAP)CompletedNCT00182312Phase 3
21Normal Pressure Hydrocephalus Treatment by AcetazolamideRecruitingNCT02163330Phase 3
22The CSF Shunt Entry Site TrialRecruitingNCT02425761Phase 3
23Quantitative Characterization of Safe Irrigation for Ventricular Shunt CathetersRecruitingNCT02651337Phase 3
24Transfusion of Prematures TrialRecruitingNCT01702805Phase 3
25Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.RecruitingNCT02684812Phase 2, Phase 3
26A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)RecruitingNCT01376778Phase 3
27Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)Active, not recruitingNCT01378273Phase 3
28EARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAHActive, not recruitingNCT01258257Phase 3
29Isoflurane-induced Neuroinflammation in Children With HydrocephalusEnrolling by invitationNCT02512809Phase 3
30ETV Versus Shunt Surgery in Normal Pressure HydrocephalusTerminatedNCT00946127Phase 3
31Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure HydrocephalusTerminatedNCT01092546Phase 3
32Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid HemorrhageUnknown statusNCT01098890Phase 2
33Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure HydrocephalusCompletedNCT00221091Phase 2
34A Study Comparing Two Treatments for Infants With HydrocephalusActive, not recruitingNCT00652470Phase 2
35Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm InfantsActive, not recruitingNCT00875758Phase 2
36WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral BleedingsTerminatedNCT01176214Phase 2
37Effect of Intraventricular tPA Following Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01878136Phase 1, Phase 2
38Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular HemorrhageRecruitingNCT02274428Phase 1
39Treatment of Subarachnoid Hemorrhage With Human AlbuminTerminatedNCT01747408Phase 1
40Magnetic Resonance Elastography in HydrocephalusUnknown statusNCT02230124
41Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure HydrocephalusUnknown statusNCT01618500
42Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure HydrocephalusUnknown statusNCT00600795
43Multimodal Investigation in the Diagnosis and Treatment of Chronic Adult HydrocephalusUnknown statusNCT02278848
44European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure HydrocephalusUnknown statusNCT00874198
45Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasound Before and After Drainage of Cerebrospinal Fluid in Patient With HydrocephalusUnknown statusNCT01863329
46Comparison of Optic Nerve Sheath Diameter on Retrobulbar Ultrasonography Before and After Drainage of Cerebrospinal Fluid in Pediatric Patient With HydrocephalusUnknown statusNCT01865149
47Prospective Follow-up of a Multicentric Cohort of Children With Prenatal Discovery of Mild Isolated Cerebral Ventriculomegaly. Evaluation at 2 and 5 Years.Unknown statusNCT00421772
48Isolated Mild Fetal Ventriculomegaly and Neurodevelopmental OutcomeUnknown statusNCT00256906
49Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled TrialUnknown statusNCT02048553
50Transcranial and Rapid Magnetic Stimulation for Gait Apraxia Due to Normal Pressure Hydrocephalus and Cerebral IschemiaUnknown statusNCT00494689

Search NIH Clinical Center for Hydrocephalus


Cochrane evidence based reviews: hydrocephalus

Genetic Tests for Hydrocephalus

About this section

Genetic tests related to Hydrocephalus:

id Genetic test Affiliating Genes
1 Hydrocephalus26

Anatomical Context for Hydrocephalus

About this section

MalaCards organs/tissues related to Hydrocephalus:

35
Brain, Testes, Spinal cord, Eye, Pituitary, Bone, Pineal

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Hydrocephalus:
id TissueAnatomical CompartmentCell Relevance
1 BrainChoroid PlexusChoroid Plexus Progenitor Cells Affected by disease
2 BrainChoroid PlexusMature Choroid Plexus Cells Affected by disease

Animal Models for Hydrocephalus or affiliated genes

About this section

MGI Mouse Phenotypes related to Hydrocephalus:

40 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053889.6DPH1, FGFR3, FLNA, FOXC1, HYDIN, STK36
2MP:00053819.4DPH1, FGFR3, FLNA, FOXC1, GFAP, POMGNT1
3MP:00053909.4DPH1, FGFR3, FLNA, FOXC1, HYDIN, L1CAM
4MP:00053898.9AKT3, CCND2, FANCB, FGFR3, FLNA, FOXC1
5MP:00028738.9AKT3, FGFR3, FLNA, FOXC1, GFAP, MAPT
6MP:00053828.9DPH1, FGFR3, FLNA, FOXC1, HYDIN, L1CAM
7MP:00053858.8AKT3, CCND2, FLNA, FOXC1, GFAP, HYDIN
8MP:00053768.2AKT3, AP1S2, CCND2, DPH1, FANCB, FGFR3
9MP:00107688.0AKT3, CCND2, DPH1, FGFR3, FLNA, FOXC1
10MP:00053847.8AKT3, AP1S2, DPH1, FANCB, FGFR3, FLNA
11MP:00053917.8CCND2, DPH1, FGFR3, FLNA, FOXC1, GFAP
12MP:00053867.6AKT3, AP1S2, CCND2, FGFR3, FLNA, GFAP
13MP:00053787.6AKT3, AP1S2, DPH1, FANCB, FGFR3, FLNA
14MP:00036317.3AKT3, AP1S2, CCND2, DPH1, FGFR3, FLNA

Publications for Hydrocephalus

About this section

Articles related to Hydrocephalus:

(show top 50)    (show all 2248)
idTitleAuthorsYear
1
Grossly calcified choroid plexus concealing foramen of Monro meningiomas as an unusual cause of obstructive hydrocephalus. (26889294)
2016
2
Timing of surgical treatment for idiopathic normal pressure hydrocephalus: association between treatment delay and reduced short-term benefit. (27581314)
2016
3
Analysis of risk factors to predict communicating hydrocephalus following gamma knife radiosurgery for intracranial schwannoma. (27882725)
2016
4
Normal pressure hydrocephalus and parkinsonism: preliminary data on neurosurgical and neurological treatment. (26970480)
2016
5
Hydrocephalus and Ventriculoperitoneal Shunts: Modes of Failure and Opportunities for Improvement. (27652453)
2016
6
The prevalence of cardiovascular disease in non-communicating hydrocephalus. (27455422)
2016
7
Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. (25666108)
2015
8
1242: ACUTE CEREBELLAR EDEMA WITH OBSTRUCTIVE HYDROCEPHALUS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS. (26570903)
2015
9
A severe case of systemic lupus erythematosus with increased pressure communicating hydrocephalus. (27708931)
2015
10
DTI-MRI biomarkers in the search for normal pressure hydrocephalus aetiology: a review. (25345377)
2014
11
Visual function in infants with congenital hydrocephalus with and without myelomeningocoele. (23904039)
2014
12
Hydrocephalus shunt technology: 20 years of experience from the Cambridge Shunt Evaluation Laboratory. (24405071)
2014
13
Evidence for spatial navigational impairments in hydrocephalus patients without spina bifida. (23959082)
2013
14
VACTERL association with hydrocephalus in a fetus conceived by inA vitro fertilization and embryo transfer. (24411047)
2013
15
Hydrocephalus in tuberculous meningitis: Incidence, its predictive factors and impact on the prognosis. (23291048)
2013
16
New and improved ways to treat hydrocephalus: Pursuit of a smart shunt. (23653889)
2013
17
Journal club: role of endoscopic third ventriculostomy and ventriculoperitoneal shunt in idiopathic normal pressure hydrocephalus: preliminary results of a randomized clinical trial. (24141398)
2013
18
Obstructive hydrocephalus caused by giant basilar artery aneurysm. (23545619)
2013
19
Normal pressure hydrocephalus in the spectrum of neurological complications of systemic lupus erythematosus. (22829132)
2013
20
Endoscopic third ventriculostomy associated 3D-construcive inference steady state MRI for obstructed hydrocephalus: a retrospective study. (23026416)
2013
21
TGF beta1 and TGF beta2 and their role in posthemorrhagic hydrocephalus following SAH and IVH. (23690072)
2013
22
Response to Letter to Editor- Pathophysiology of Acute Hydrocephalus after Subarachnoid Hemorrhage. (23948648)
2013
23
Visual disturbance following shunt malfunction in a patient with congenital hydrocephalus. (23183081)
2012
24
Microscopic supraciliary approach for terminal laminotomy for treatment of hydrocephalus: a preliminary report of eight cases. (23015337)
2012
25
Assessment of a quick reference table algorithm for determining initial postoperative pressure settings of programmable pressure valves in patients with idiopathic normal pressure hydrocephalus: SINPHONI subanalysis. (22653392)
2012
26
Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases. (19747042)
2010
27
From apneic spells to the development of hypertensive hydrocephalus: a case report of homocystinuria with early onset. (19509410)
2010
28
CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus. (19046799)
2009
29
Normal pressure hydrocephalus after radiosurgery for sphenoid ridge meningioma. (19013812)
2009
30
Clinical improvement in two dogs with hydrocephalus and syringohydromyelia after ventriculoperitoneal shunting. (18271823)
2008
31
Idiopathic normal pressure hydrocephalus: increased supplementary motor activity accounts for improvement after CSF drainage. (18931387)
2008
32
Gait disturbance in normal pressure hydrocephalus: a clinical study. (17052947)
2007
33
Factors affecting the outcome of neuroendoscopy in patients with tuberculous meningitis hydrocephalus: a preliminary study. (17586218)
2007
34
Megalencephaly and perisylvian polymicrogyria with postaxial polydactyly and hydrocephalus: a rare brain malformation syndrome associated with mental retardation and seizures. (15627943)
2004
35
Pulse wave encephalopathy: a spectrum hypothesis incorporating Alzheimer's disease, vascular dementia and normal pressure hydrocephalus. (14962623)
2004
36
Giant fusiform basilar artery aneurysm causing obstructive hydrocephalus. (17167680)
2002
37
A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. (11148530)
2001
38
Hydrocephalus in pfeiffer syndrome. (18638762)
1994
39
Intermittent downbeat nystagmus secondary to vermian arachnoid cyst with associated obstructive hydrocephalus. (1838553)
1991
40
Hydrocephalus of intrauterine onset in perinatally lethal osteogenesis imperfecta: clinical, sonographic, and pathologic correlations. (3062601)
1988
41
The value of CSF flow studies in infants with communicating hydrocephalus. (3779670)
1986
42
CSF dynamics and pressure-volume relationships in communicating hydrocephalus. (3941350)
1986
43
Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. (3772453)
1986
44
Gait apraxia in communicating hydrocephalus. (7241157)
1981
45
Ultrastructure of the ependyma in the lateral ventricles of primates with experimental communicating hydrocephalus. (118517)
1979
46
Pathophysiology of chronic communicating hydrocephalus in dogs (Canis familiaris). Experimental studies. (1172782)
1975
47
Chronic communicating hydrocephalus with normal CSE pressures: a cisternographic-pathologic correlation. (4462439)
1974
48
Use of silastic to produce communicating hydrocephalus. (4690951)
1973
49
Hydrodynamic properties of certain shunt assemblies for the treatment of hydrocephalus. l. Report of a case of communicating hydrocephalus with increased cerebrospinal fluid production treated by duplication of shunting device. 2. Pressure-flow characteristics of the Spitz-Holter, Pudenz-Heyer, and Cordis-Hakim shunt systems. (5306449)
1969
50
A Case of Encephalocele: Removal: Hydrocephalus: Death. (20754704)
1894

Variations for Hydrocephalus

About this section

Clinvar genetic disease variations for Hydrocephalus:

5 (show all 14)
id Gene Variation Type Significance SNP ID Assembly Location
1L1CAMNM_000425.4(L1CAM): c.719C> T (p.Pro240Leu)SNVPathogenicrs137852526GRCh37Chr X, 153135930: 153135930
2DPH1NM_001383.3(DPH1): c.701T> C (p.Leu234Pro)SNVLikely pathogenic, Pathogenicrs730882250GRCh38Chr 17, 2039760: 2039760
3L1CAMNM_000425.4(L1CAM): c.924C> T (p.Gly308=)SNVLikely pathogenic, Pathogenicrs797044787GRCh37Chr X, 153135578: 153135578
4L1CAMNM_000425.4(L1CAM): c.2380C> T (p.Gln794Ter)SNVPathogenicrs875989884GRCh37Chr X, 153132155: 153132155
546;XY;inv(1)(p22.3p34.1)dnTranslocationPathogenicChr na, -1: -1
6L1CAMNM_000425.4(L1CAM): c.3458-1G> CSNVPathogenicrs879253724GRCh37Chr X, 153129005: 153129005
7L1CAMNM_000425.4(L1CAM): c.23delT (p.Val8Glyfs)deletionPathogenicrs398123362GRCh37Chr X, 153141269: 153141269
8L1CAMNM_000425.4(L1CAM): c.2879delA (p.Glu960Glyfs)deletionPathogenicrs398123364GRCh37Chr X, 153130443: 153130443
9L1CAMNM_000425.4(L1CAM): c.2432-19A> CSNVPathogenicrs879253713GRCh37Chr X, 153131293: 153131293
10L1CAMNM_000425.4(L1CAM): c.791G> A (p.Cys264Tyr)SNVPathogenicrs137852518GRCh37Chr X, 153135858: 153135858
11L1CAML1CAM, 1.3-KB DUPduplicationPathogenicChr na, -1: -1
12L1CAMNM_000425.4(L1CAM): c.1354G> A (p.Gly452Arg)SNVPathogenicrs137852520GRCh37Chr X, 153134321: 153134321
13L1CAMNM_000425.4(L1CAM): c.551G> A (p.Arg184Gln)SNVPathogenicrs137852521GRCh37Chr X, 153136388: 153136388
14L1CAMNM_000425.4(L1CAM): c.3581C> T (p.Ser1194Leu)SNVPathogenicrs137852522GRCh37Chr X, 153128311: 153128311

Expression for genes affiliated with Hydrocephalus

About this section
Search GEO for disease gene expression data for Hydrocephalus.

Pathways for genes affiliated with Hydrocephalus

About this section

GO Terms for genes affiliated with Hydrocephalus

About this section

Biological processes related to Hydrocephalus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of transcription factor import into nucleusGO:004299310.0FLNA, PIK3R2
2brain developmentGO:00074209.3FOXC1, MAPT, NES, STK36

Molecular functions related to Hydrocephalus according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein bindingGO:00055155.6AKT3, AP1S2, CCDC88C, CCND2, DPH1, FANCB

Sources for Hydrocephalus

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet